So Young Medical Apologizes to Ma Sichun, Initiates Internal Review and Accountability

Deep News
06/12

On the evening of June 12th, So Young Medical issued a statement on social media, offering a formal apology to actress Ma Sichun, her family, her fans, and the general public regarding a recent article with a highly inappropriate title.

The company explained that on June 11th, its official WeChat public account published an article titled "Ma Sichun, Died at Age 37." The title was derived from a segment in a previous public interview where Ma Sichun discussed writing her own obituary as a life reflection exercise. However, the title was taken out of context and used severely inappropriate wording, creating ambiguity and causing serious offense to Ma Sichun and her family, as well as alarming and misleading her fans and the wider online community.

So Young expressed its sincere apologies to Ma Sichun, her family, and her fans, and to all those disturbed by the headline. The company acknowledged that the publication of such an improper title exposed flaws in its review process, with primary responsibility lying with management.

The company outlined the actions it has taken and will continue to implement. First, the offending article was immediately removed, and a review of all historical content across its platforms has been conducted. Second, a comprehensive upgrade of the multi-level review mechanism for titles and content is underway. Third, an internal review and accountability process has been initiated.

So Young stated that Ma Sichun's candid sharing of her reflections on life in that interview deserved to be treated with seriousness and respect, and the headline failed to do so, which is the core issue requiring reflection. The company reiterated its apology.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10